insights_auto
Why is EPRX up 2.73%?
Dive Deeperchevron_right
EPRX:NASDAQ
Eupraxia Pharmaceuticals Inc
$6.77
arrow_upward
+2.73%(+0.18) 1D
$6.77
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 15, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EPRX...
Open
$6.60
High
$6.82
Low
$6.49
Mkt. cap
626.13M
Avg. vol.
893.75K
Volume
466.97K
52-wk high
$9.31
52-wk low
$5.25
Beta
1.05
Shares outstanding
65.91M
No. of employees
49
Open
$6.60
High
$6.82
Low
$6.49
Mkt. cap
626.13M
Avg. vol.
893.75K
Volume
466.97K
52-wk high
$9.31
52-wk low
$5.25
Beta
1.05
Shares outstanding
65.91M
No. of employees
49
News stories
From web sources and news partners
Stock Titan
·
6 hours ago
Trial enrollment hits its target at Eupraxia (EPRX), with interim data expected in December 2026.
Simply Wall Street
·
8 hours ago
Eupraxia Pharmaceuticals (TSE:EPRX) Is In A Good Position To Deliver On Growth Plans
Kalkine Media
·
3 days ago
Can (TSX:EPRX) Eupraxia Prove Its One-Shot Esophagus Therapy Holds Up Over Time?
About Eupraxia Pharmaceuticals Inc
CEO-
Employees49
Founded2011
HeadquartersVictoria, British Columbia, Canada
SectorBiotechnology
Websiteeupraxiapharma.com